Burkitt's lymphoma in Ghana: clinical features and response to chemotherapy.
D000008:Abdominal Neoplasms / Q000188:drug therapy; D000293:Adolescent; D000493:Allopurinol / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000188:drug therapy; D002051:Burkitt Lymphoma / Q000188:drug therapy* / Q000401:mortality; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D005869:Ghana; D006801:Humans; D007573:Jaw Neoplasms / Q000188:drug therapy; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D009364:Neoplasm Recurrence, Local; D009378:Neoplasms, Multiple Primary; D009461:Neurologic Manifestations; D010051:Ovarian Neoplasms / Q000188:drug therapy; D011379:Prognosis; D012737:Sex Factors; D013997:Time Factors; D014750:Vincristine / Q000627:therapeutic use
D014750:Vincristine; D000493:Allopurinol; D003520:Cyclophosphamide; D008727:Methotrexate